Artwork

Sisällön tarjoaa Alex Jani: interviewing visionaries of healthcare innovation. Alex Jani: interviewing visionaries of healthcare innovation tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Getting Rid of Injections for Diabetes and Other Drugs? Dr. David Klein Cerrejon, OBaris

46:21
 
Jaa
 

Manage episode 425589730 series 3469528
Sisällön tarjoaa Alex Jani: interviewing visionaries of healthcare innovation. Alex Jani: interviewing visionaries of healthcare innovation tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

If you are a person with diabetes, you already know that some drugs cannot be administered other than via injections. Today’s guest works on a solution for these medications to be taken from the inside of the cheek.

You’ll hear:

  • how different kinds of drugs are absorbed
  • why some drugs, macromolecular drugs, such as the ones for diabetes, need to be delivered in injections
  • how Obaris has overcome this problem
  • how drugs such as Ozempic or Mounjaro could be administered painlessly

Dr. David Klein Cerrejon is the CEO of Obaris, a chemist with a PhD in pharmaceutical science specializing in drug delivery.
Obaris is a Swiss startup, an ETH spin-off, that develops Octo-Patch, a small, painless patch, resembling an octopus sucker, that you can stick to the inner side of the cheek to administer drugs that are now available only in injections.

Here is more about Obaris:

https://obaris.ch/

If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.

  continue reading

Luvut

1. Dr. David Klein Cerrejon and OBaris (00:00:00)

2. Why Diabetes and Osteoporosis Drugs Have to Be Injected (Currently) (00:01:13)

3. Peppercorn at the Root of Peptide Drugs Delivery via Inside of the Cheek (00:07:02)

4. Nature-Inspired Shape: Octopus Sucker for a Suction Cup (00:11:53)

5. Future of Drugs Such As Ozempic or Mounjaro Administration (00:17:27)

6. Shifting the Paradigm in Peptide Drug Delivery (00:27:09)

7. Drug Combination Development Roadmap (00:35:47)

8. Thank You, Follow OBaris (00:44:34)

9. Follow X-Health.show, Disclaimer (00:45:00)

69 jaksoa

Artwork
iconJaa
 
Manage episode 425589730 series 3469528
Sisällön tarjoaa Alex Jani: interviewing visionaries of healthcare innovation. Alex Jani: interviewing visionaries of healthcare innovation tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

If you are a person with diabetes, you already know that some drugs cannot be administered other than via injections. Today’s guest works on a solution for these medications to be taken from the inside of the cheek.

You’ll hear:

  • how different kinds of drugs are absorbed
  • why some drugs, macromolecular drugs, such as the ones for diabetes, need to be delivered in injections
  • how Obaris has overcome this problem
  • how drugs such as Ozempic or Mounjaro could be administered painlessly

Dr. David Klein Cerrejon is the CEO of Obaris, a chemist with a PhD in pharmaceutical science specializing in drug delivery.
Obaris is a Swiss startup, an ETH spin-off, that develops Octo-Patch, a small, painless patch, resembling an octopus sucker, that you can stick to the inner side of the cheek to administer drugs that are now available only in injections.

Here is more about Obaris:

https://obaris.ch/

If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.

  continue reading

Luvut

1. Dr. David Klein Cerrejon and OBaris (00:00:00)

2. Why Diabetes and Osteoporosis Drugs Have to Be Injected (Currently) (00:01:13)

3. Peppercorn at the Root of Peptide Drugs Delivery via Inside of the Cheek (00:07:02)

4. Nature-Inspired Shape: Octopus Sucker for a Suction Cup (00:11:53)

5. Future of Drugs Such As Ozempic or Mounjaro Administration (00:17:27)

6. Shifting the Paradigm in Peptide Drug Delivery (00:27:09)

7. Drug Combination Development Roadmap (00:35:47)

8. Thank You, Follow OBaris (00:44:34)

9. Follow X-Health.show, Disclaimer (00:45:00)

69 jaksoa

Kaikki jaksot

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas